[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001288357A1 - Methods of preventing or treating west nile virus and other infections - Google Patents

Methods of preventing or treating west nile virus and other infections

Info

Publication number
AU2001288357A1
AU2001288357A1 AU2001288357A AU8835701A AU2001288357A1 AU 2001288357 A1 AU2001288357 A1 AU 2001288357A1 AU 2001288357 A AU2001288357 A AU 2001288357A AU 8835701 A AU8835701 A AU 8835701A AU 2001288357 A1 AU2001288357 A1 AU 2001288357A1
Authority
AU
Australia
Prior art keywords
infections
preventing
methods
west nile
nile virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288357A
Inventor
James J. Rahal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Hospital Medical Center of Queens
Original Assignee
NEW YORK HOSPITAL MEDICAL CT O
New York Hospital Medical Center of Queens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEW YORK HOSPITAL MEDICAL CT O, New York Hospital Medical Center of Queens filed Critical NEW YORK HOSPITAL MEDICAL CT O
Publication of AU2001288357A1 publication Critical patent/AU2001288357A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2214—Motilins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001288357A 2000-08-23 2001-08-23 Methods of preventing or treating west nile virus and other infections Abandoned AU2001288357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22742200P 2000-08-23 2000-08-23
US60/227,422 2000-08-23
PCT/US2001/026301 WO2002015664A2 (en) 2000-08-23 2001-08-23 Methods of preventing or treating west nile virus and other infections

Publications (1)

Publication Number Publication Date
AU2001288357A1 true AU2001288357A1 (en) 2002-03-04

Family

ID=22853052

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288357A Abandoned AU2001288357A1 (en) 2000-08-23 2001-08-23 Methods of preventing or treating west nile virus and other infections

Country Status (3)

Country Link
US (1) US6946125B2 (en)
AU (1) AU2001288357A1 (en)
WO (1) WO2002015664A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425437B2 (en) * 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
US20060024270A1 (en) * 2000-08-23 2006-02-02 The New York Hospital Medical Center Of Queens Compositions and methods for preventing or treating encephalitis with interferon
CA2498319A1 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
WO2004062676A1 (en) * 2003-01-09 2004-07-29 F. Hoffmann-La Roche Ag -modified nucleoside derivatives for treating flaviviridae infections
CN1832755A (en) * 2003-05-23 2006-09-13 佩斯特卡生物医疗实验室公司 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
AU2005318171B2 (en) 2004-12-20 2011-09-29 Crucell Holland B.V. Binding molecules capable of neutralizing West Nile virus and uses thereof
AU2006245734C1 (en) 2005-05-12 2012-05-24 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
WO2006136601A1 (en) * 2005-06-23 2006-12-28 Crucell Holland B.V. Optimization of west nile virus antibodies
NZ572773A (en) * 2006-06-06 2011-11-25 Crucell Holland Bv Human binding molecules having killing activity against staphylococci and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection

Also Published As

Publication number Publication date
WO2002015664A3 (en) 2002-08-08
US6946125B2 (en) 2005-09-20
WO2002015664A2 (en) 2002-02-28
US20020061290A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AU2001243219A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
AU4562701A (en) Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2002346686A1 (en) Compositions and method for treating hepatitis virus infection
AU2002323270A1 (en) Composition and method for treating hiv infection
AU2001288357A1 (en) Methods of preventing or treating west nile virus and other infections
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU2002324753A1 (en) Composition and method for treating viral infection
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002365168A1 (en) Method and composition for treating and preventing hiv infection and aids
AU1808501A (en) Tricyclic compounds and method of treating herpes virus
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002366268A1 (en) Novel coumarin and chromene compounds and methods of treating or preventing viral infections
AU2001234596A1 (en) Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU2001288870A1 (en) Antiviral compounds and method of treating viral infections
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
HUP0200466A3 (en) Lipoglycan compositions and methods of treating parasitic infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii